Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.84 USD | +2.56% | -0.33% | 0.00% |
06-24 | ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P Global BMI Index | CI |
06-05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- AVBP Stock
- Revisions ArriVent BioPharma, Inc.